Low Zinc Levels at Admission Associates with Poor Clinical Outcomes in SARS-CoV-2 Infection
Marina Vogel-González, Marc Talló-Parra, Víctor Herrera-Fernández, Gemma Pérez-Vilaró, Miguel Chillón, Xavier Nogués, Silvia Gómez-Zorrilla, Inmaculada López-Montesinos, Isabel Arnau-Barrés, Maria Luisa Sorli-Redó, Juan Pablo Horcajada, Natalia García-Giralt, Julio Pascual, Juana Díez, Rubén Vicente, Robert Güerri-Fernández
Nutrients, doi:10.3390/nu13020562
Background: Zinc is an essential micronutrient that impacts host-pathogen interplay at infection. Zinc balances immune responses, and also has a proven direct antiviral action against some viruses. Importantly, zinc deficiency (ZD) is a common condition in elderly and individuals with chronic diseases, two groups with an increased risk for severe severe coronavirus disease 2019 (COVID-19) outcomes. We hypothesize that serum zinc content (SZC) influences COVID-19 disease progression, and thus might represent a useful biomarker. Methods: We ran an observational cohort study with 249 COVID-19 patients admitted in Hospital del Mar. We have studied COVID-19 severity and progression attending to SZC at admission. In parallel, we have studied severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) replication in the Vero E6 cell line modifying zinc concentrations. Findings: Our study demonstrates a correlation between serum zinc levels and COVID-19 outcome. Serum zinc levels lower than 50 µg/dL at admission correlated with worse clinical presentation, longer time to reach stability, and higher mortality. Our in vitro results indicate that low zinc levels favor viral expansion in SARS-CoV-2 infected cells. Interpretation: Low SZC is a risk factor that determines COVID-19 outcome. We encourage performing randomized clinical trials to study zinc supplementation as potential prophylaxis and treatment with people at risk of zinc deficiency.
Institutional Review Board Statement: The study was conducted according to the guidelines of the Declaration of Helsinki, and was approved by the Institutional Review Board (IRB; the Institutional Ethics Committee of the Hospital del Mar of Barcelona (CEIm-2020/9352)). Due to the nature of the retrospective data review, the IRB waived the need for informed consent from individual patients. Informed Consent Statement: Due to the nature of the retrospective data review, the IRB waived the need for informed consent from individual patients.
Conflicts of Interest: The authors declare no conflict of interest.
References
Bao, Prasad, Beck, Fitzgerald, Snell et al., Zinc decreases C-reactive protein, lipid peroxidation, and inflammatory cytokines in elderly subjects: A potential implication of zinc as an atheroprotective agent, Am. J. Clin. Nutr,
doi:10.3945/ajcn.2009.28836
Beck, Prasad, Kaplan, Fitzgerald, Brewer, Changes in cytokine production and T cell subpopulations in experimentally induced zinc-deficient humans, Am. J. Physiol,
doi:10.1152/ajpendo.1997.272.6.E1002
Besecker, Exline, Hollyfield, Phillips, Disilvestro et al., A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission, Am. J. Clin. Nutr,
doi:10.3945/ajcn.110.008417
Boulware, Pullen, Bangdiwala, Pastick, Lofgren et al., A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for COVID-19, N. Engl. J. Med,
doi:10.1056/NEJMoa2016638
Carlucci, Ahuja, Petrilli, Rajagopalan, Jones et al., Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients, J. Med. Microbiol,
doi:10.1099/jmm.0.001250
Cavalcanti, Zampieri, Rosa, Azevedo, Veiga et al., Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate COVID-19, N. Engl. J. Med,
doi:10.1056/NEJMoa2019014
Chen, Wu, Guo, Cao, Huang et al., Clinical and immunological features of severe and moderate coronavirus disease 2019, J. Clin. Investig,
doi:10.1172/JCI137244
Derwand, Scholz, Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?, Med. Hypotheses,
doi:10.1016/j.mehy.2020.109815
Derwand, Scholz, Zelenko, York, COVID-19 outpatients-Early risk-stratified treatment with zinc plus low dose hydroxychloroquine and azithromycin: A retrospective case series study, Int. J. Antimicrob. Agents,
doi:10.1016/j.ijantimicag.2020.106214
Gorshkov, Chen, Bostwick, Rasmussen, Xu et al., The SARS-CoV-2 cytopathic effect is blocked with autophagy modulators, bioRxiv,
doi:10.1101/2020.05.16.091520
Hasan, Rink, Haase, Chelation of Free Zn 2+ Impairs Chemotaxis, Phagocytosis, Oxidative Burst, Degranulation, and Cytokine Production by Neutrophil Granulocytes, Biol. Trace Elem. Res,
doi:10.1007/s12011-015-0515-0
Hasan, Rink, Haase, Zinc signals in neutrophil granulocytes are required for the formation of neutrophil extracellular traps, Innate Immun,
doi:10.1177/1753425912458815
Heller, Sun, Hackler, Seelig, Seibert et al., Prediction of survival odds in COVID-19 by zinc, age and selenoprotein P as composite biomarker, Redox Biol,
doi:10.1016/j.redox.2020.101764
Jarosz, Olbert, Wyszogrodzka, Młyniec, Librowski, Antioxidant and anti-inflammatory effects of zinc. Zincdependent NF-jB signaling, Inflammopharmacology,
doi:10.1007/s10787-017-0309-4
Jothimani, Kailasam, Danielraj, Nallathambi, Ramachandran et al., COVID-19: Poor outcomes in patients with zinc deficiency, Int. J. Infect. Dis,
doi:10.1016/j.ijid.2020.09.014
Liu, Cao, Xu, Wang, Zhang et al., Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro, Cell Discov,
doi:10.1038/s41421-020-0156-0
Liuzzi, Lichten, Rivera, Blanchard, Aydemir et al., Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response, Proc. Natl. Acad. Sci,
doi:10.1073/pnas.0502257102
Mauthe, Orhon, Rocchi, Zhou, Luhr et al., Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion, Autophagy,
doi:10.1080/15548627.2018.1474314
Prasad, Beck, Bao, Fitzgerald, Snell et al., Zinc supplementation decreases incidence of infections in the elderly: Effect of zinc on generation of cytokines and oxidative stress, Am. J. Clin. Nutr,
doi:10.1093/ajcn/85.3.837
Science, Johnstone, Roth, Guyatt, Loeb, Zinc for the treatment of the common cold: A systematic review and meta-analysis of randomized controlled trials, CMAJ,
doi:10.1503/cmaj.111990
Subbe, Davies, Williams, Rutherford, Gemmell, Effect of introducing the Modified Early Warning score on clinical outcomes, cardio-pulmonary arrests and intensive care utilisation in acute medical admissions, Anaesthesia,
doi:10.1046/j.1365-2044.2003.03258.x
Velthuis, Van Den Worm, Sims, Baric, Snijder et al., Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture, PLoS Pathog,
doi:10.1371/journal.ppat.1001176
Wessells, King, Brown, Development of a Plasma Zinc Concentration Cutoff to Identify Individuals with Severe Zinc Deficiency Based on Results from Adults Undergoing Experimental Severe Dietary Zinc Restriction and Individuals with Acrodermatitis Enteropathica, J. Nutr,
doi:10.3945/jn.114.191585
Wessels, Haase, Engelhardt, Rink, Uciechowski, Zinc deficiency induces production of the proinflammatory cytokines IL-1β and TNFα in promyeloid cells via epigenetic and redox-dependent mechanisms, J. Nutr. Biochem,
doi:10.1016/j.jnutbio.2012.06.007
Wong, Dashner-Titus, Alvarez, Chase, Hudson et al., Zinc Deficiency and Arsenic Exposure Can Act Both Independently or Cooperatively to Affect Zinc Status, Oxidative Stress, and Inflammatory Response, Biol. Trace Elem. Res,
doi:10.1007/s12011-019-1631-z
Yao, Ye, Zhang, Cui, Huang et al., In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Clin. Infect. Dis,
doi:10.1093/cid/ciaa237
Yasuda, Tsutsui, Infants and elderlies are susceptible to zinc deficiency, Sci. Rep,
doi:10.1038/srep21850